Vimarsana
Biggest News Aggregation in the World

Page 17 - Johnson Amp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Johnson Amp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Johnson Amp Today - Breaking & Trending Today

Drugmakers under fire on Capitol Hill seek to turn up heat on market middlemen - Vimarsana News

Drugmakers under fire on Capitol Hill seek to turn up heat on market middlemen

Drugmakers grilled on the cost of prescription drugs on Capitol Hill Thursday sought to deflect the criticism onto drug-market middlemen who they said are...

Big Pharma CEOs address high drug costs on Capitol Hill - Vimarsana News

Big Pharma CEOs address high drug costs on Capitol Hill

For too many Americans, the drugs prescribed by their doctor are out of reach.

King Cash Is Being Dethroned. What to Buy Now. - Vimarsana News

King Cash Is Being Dethroned. What to Buy Now.

Consider short-term bond ETFs from Vanguard, dividends, and growth stocks.

Merck, J&J and Bristol Myers CEOs face drug-pricing grilling on Capitol Hill - Vimarsana News

Merck, J&J and Bristol Myers CEOs face drug-pricing grilling on Capitol Hill

Lawmakers seeking to hold drugmakers accountable for high prescription-drug costs are focusing on some prices that shed little light on the problem,...

Investigational targeted oral peptide JNJ-2113 demonstrated positive results in moderate-to-severe plaque psoriasis in Phase 2b study published in New England Journal of Medicine - Vimarsana News

Investigational targeted oral peptide JNJ-2113 demonstrated positive results in moderate-to-severe plaque psoriasis in Phase 2b study published in New England Journal of Medicine

/PRNewswire/ -- Johnson & Johnson today announced publication in the New England Journal of Medicine (NEJM) of the Phase 2b FRONTIER 1 trial results for...